MedTrace Logo

Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet

NCT02065648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-02-12

No results posted yet for this study

Summary

The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE sequence is a viable alternative to contrast enhanced MRA in patients with renal insufficiency. There are no interventions--this is an observational study.

Conditions

  • Vascular Disease

Sponsors & Collaborators

  • Siemens Corporation, Corporate Technology

    collaborator INDUSTRY

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Rola Saouaf, MD · Cedars-Sinai Medical Center

  • Franklin G. Moser, MD · Cedars-Sinai Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02065648 on ClinicalTrials.gov